Status:
COMPLETED
Drug Use Investigation On Zithromac (Azithromycin) In HIV Patients
Lead Sponsor:
Pfizer
Collaborating Sponsors:
Altmarc Inc.
Conditions:
HIV Infection
Eligibility:
All Genders
Brief Summary
The investigation will be conducted for the purpose of determining the condition of occurrence of Adverse Events under the actual post-marketing use of Zithromac 600mg Tablet, verifying the therapeuti...
Detailed Description
All the patients whom an investigator prescribes the first Zithromac Tablets 600mg should be registered consecutively until the number of subjects reaches target number in order to extract patients en...
Eligibility Criteria
Inclusion
- Patients need to be administered Zithromac Tablets 600mg in order to be enrolled in the surveillance.
Exclusion
- Patients not administered Zithromac Tablets 600mg.
Key Trial Info
Start Date :
July 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
476 Patients enrolled
Trial Details
Trial ID
NCT01227395
Start Date
July 1 2002
End Date
March 1 2012
Last Update
April 26 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.